LC
IRON icon

Lindbrook Capital’s Disc Medicine IRON Stock Holding History

Lindbrook Capital’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$2.88K Buy
+58
New +$3.23K ﹤0.01% 2164
2024
Q2 		– Sell
-67
Closed -$4.17K – 2800
2024
Q1 		$4.17K Buy
+67
New +$4.34K ﹤0.01% 1975

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lindbrook Capital's IRON Position: Q1 2025 in Review

Lindbrook Capital opened a new position in Disc Medicine (IRON) in Q1 2025: 58 shares worth $2.88K. The stake represents ﹤0.01% of the portfolio and ranks #2164 among its holdings. This is a return to the name: Lindbrook Capital previously reported a position in IRON as recently as Q1 2024.

Lindbrook Capital first reported a position in IRON in Q1 2024 and has held it in 2 quarters since. The position peaked at $4.17K in Q1 2024. 157 funds tracked by Wall St. Rank hold IRON as of Q1 2025.

  • Lindbrook Capital held 58 shares of Disc Medicine worth $2.88K as of Q1 2025.
  • Disc Medicine was a new Lindbrook Capital position in Q1 2025.
  • Disc Medicine made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2164 holding.
  • Lindbrook Capital first reported a position in Disc Medicine in Q1 2024 and has held it in 2 quarters since.
  • Lindbrook Capital's Disc Medicine position peaked at $4.17K in Q1 2024.
  • 157 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.